Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juan An

Showing results (111-120 of 136) with videos related to

Pageof 14
Sort By:
Medical Oncology (Northwood, London, England)|April 5, 2011
Posttreatment plasma VEGF levels may be associated with the overall survival of patients with advanced non-small cell lung cancer treated with bevacizumab plus chemotherapyShe-Juan An, Yi-Sheng Huang, Zhi-Hong Chen, et al.
International Journal of Nanomedicine|October 29, 2020
Glucose-coated Berberine Nanodrug for Glioma Therapy through Mitochondrial PathwayShubin Wang, Juan An, Weiwei Dong, et al.
The International Journal of Biological Markers|December 23, 2015
Polymorphism of rs9387478 correlates with overall survival in female nonsmoking patients with lung cancerJie-Fei Han, She-Juan An, Wen-Mei Su, et al.
The Oncologist|September 17, 2014
Lung cancer treatment disparities in China: a question in need of an answerLu-Lu Yang, Xu-Chao Zhang, Xue-Ning Yang, et al.
Plos One|July 7, 2012
Identification of enriched driver gene alterations in subgroups of non-small cell lung cancer patients based on histology and smoking statusShe-Juan An, Zhi-Hong Chen, Jian Su, et al.
The Oncologist|June 8, 2012
EGFR mutation heterogeneity and the mixed response to EGFR tyrosine kinase inhibitors of lung adenocarcinomasZhi-Yong Chen, Wen-Zhao Zhong, Xu-Chao Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 27, 2011
Relative abundance of EGFR mutations predicts benefit from gefitinib treatment for advanced non-small-cell lung cancerQing Zhou, Xu-Chao Zhang, Zhi-Hong Chen, et al.
Journal of Cancer Research and Clinical Oncology|May 5, 2007
KDR expression is associated with the stage and cigarette smoking of the patients with lung cancerShe-Juan An, Qiang Nie, Zhi-Hong Chen, et al.
Nature|February 6, 2023
Author Correction: Senescence atlas reveals an aged-like inflamed niche that blunts muscle regenerationVictoria Moiseeva, Andrés Cisneros, Valentina Sica, et al.
Nature|December 21, 2022
Senescence atlas reveals an aged-like inflamed niche that blunts muscle regenerationVictoria Moiseeva, Andrés Cisneros, Valentina Sica, et al.
Pageof 14

Showing results (111-120 of 136) with videos related to

Sort By:
Pageof 14
Medical Oncology (Northwood, London, England)|April 5, 2011
Posttreatment plasma VEGF levels may be associated with the overall survival of patients with advanced non-small cell lung cancer treated with bevacizumab plus chemotherapyShe-Juan An, Yi-Sheng Huang, Zhi-Hong Chen, et al.
International Journal of Nanomedicine|October 29, 2020
Glucose-coated Berberine Nanodrug for Glioma Therapy through Mitochondrial PathwayShubin Wang, Juan An, Weiwei Dong, et al.
The International Journal of Biological Markers|December 23, 2015
Polymorphism of rs9387478 correlates with overall survival in female nonsmoking patients with lung cancerJie-Fei Han, She-Juan An, Wen-Mei Su, et al.
The Oncologist|September 17, 2014
Lung cancer treatment disparities in China: a question in need of an answerLu-Lu Yang, Xu-Chao Zhang, Xue-Ning Yang, et al.
Plos One|July 7, 2012
Identification of enriched driver gene alterations in subgroups of non-small cell lung cancer patients based on histology and smoking statusShe-Juan An, Zhi-Hong Chen, Jian Su, et al.
The Oncologist|June 8, 2012
EGFR mutation heterogeneity and the mixed response to EGFR tyrosine kinase inhibitors of lung adenocarcinomasZhi-Yong Chen, Wen-Zhao Zhong, Xu-Chao Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 27, 2011
Relative abundance of EGFR mutations predicts benefit from gefitinib treatment for advanced non-small-cell lung cancerQing Zhou, Xu-Chao Zhang, Zhi-Hong Chen, et al.
Journal of Cancer Research and Clinical Oncology|May 5, 2007
KDR expression is associated with the stage and cigarette smoking of the patients with lung cancerShe-Juan An, Qiang Nie, Zhi-Hong Chen, et al.
Nature|February 6, 2023
Author Correction: Senescence atlas reveals an aged-like inflamed niche that blunts muscle regenerationVictoria Moiseeva, Andrés Cisneros, Valentina Sica, et al.
Nature|December 21, 2022
Senescence atlas reveals an aged-like inflamed niche that blunts muscle regenerationVictoria Moiseeva, Andrés Cisneros, Valentina Sica, et al.
Pageof 14